Definitive Healthcare Q3 revenue $65.3M (+14% YoY); net loss widens to $248.7M on non-cash charges

Definitive Healthcare Corp.

2023-Q3 EPS reported -$1.72 revenue$185,483,000

Revenue $65.3M, up 14% YoY from $57.4M; above high-end of guidance.
Net loss $248.7M (381% of revenue) vs $6.9M loss in Q3 2022; adjusted net income $14.6M.
Adjusted EBITDA $21.7M (33% of revenue) vs $16.4M (29%) a year ago.
Q4 guidance: revenue $65.5M-$66.5M, adjusted EPS $0.06-$0.08 on 155.6M diluted shares.
Enterprise customers grew 10% YoY to 555; customer win-backs and expansions noted.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Definitive Healthcare Corp. reported the quarter ended September 30, 2023 results: revenue $65.3 million, net income $(248.7) million.

Period: the quarter ended September 30, 2023
Revenue: $65.3 million
Net income: $(248.7) million
Result: reported results

Exact text from the filing

EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023 Third quarter revenue grew 14% year-over-year to $65.3 million Framingham, MA (November 2, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-23-058213

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.